We are live on ! Find out more
PVAM

Pacific View Asset Management Portfolio holdings

AUM $20.8M
1-Year Est. Return 20.08%
This Fund
S&P 500
This Quarter Est. Return
+1%
1 Year Est. Return
+20.08%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
-$683K
Cap. Flow
-$1.12M
Cap. Flow %
-0.89%
Top 10 Hldgs %
43.82%
Holding
100
New
5
Increased
28
Reduced
51
Closed
13

Top Buys

Rank Stock Value
1
LMB icon
Limbach Holdings
LMB
+$2.96M
2
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$2.51M
3
IMMU
Immunomedics Inc
IMMU
+$2.46M
4
ARRY
Array Biopharma Inc
ARRY
+$1.99M
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$1.86M

Top Sells

Rank Stock Value
1
SAGE
Sage Therapeutics
SAGE
+$4.13M
2
PRAH
PRA Health Sciences, Inc.
PRAH
+$2.98M
3
KIN
Kindred Biosciences, Inc.
KIN
+$2.73M
4
GDXJ icon
VanEck Junior Gold Miners ETF
GDXJ
+$1.84M
5
ADSW
Advanced Disposal Services Inc
ADSW
+$1.63M

Sector Composition

Rank Sector Weight
1 Industrials 21.06%
2 Healthcare 20.12%
3 Financials 13.58%
4 Technology 10.99%
5 Consumer Staples 6.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLAY icon
76
Dave & Buster's
PLAY
$357M
$302K 0.24%
4,578
-5,809
-56% -$315K
EFOR
77
Everforth Inc
EFOR
$960M
$289K 0.23%
3,679
-96
-3% -$8.29K
SUPN icon
78
Supernus Pharmaceuticals
SUPN
$2.7B
$288K 0.23%
5,711
-121
-2% -$5.97K
IBP icon
79
Installed Building Products
IBP
$6.21B
$287K 0.23%
7,405
-135
-2% -$6.8K
RARE icon
80
Ultragenyx Pharmaceutical
RARE
$2.46B
$269K 0.21%
3,526
-96
-3% -$7.81K
FOLD
81
DELISTED
Amicus Therapeutics
FOLD
$253K 0.2%
21,088
-434
-2% -$6.07K
PFPT
82
DELISTED
Proofpoint, Inc.
PFPT
$253K 0.2%
2,375
-63
-3% -$7.33K
ANAB icon
83
AnaptysBio
ANAB
$1.54B
$245K 0.2%
+2,470
New +$205K
KYNB
84
Kyntra Bio
KYNB
$27.4M
$239K 0.19%
157
-4
-2% -$6.16K
SLAB icon
85
Silicon Laboratories
SLAB
$7.14B
$239K 0.19%
2,608
-73
-3% -$7.13K
LPX icon
86
Louisiana-Pacific
LPX
$5.14B
$237K 0.19%
8,887
-228
-3% -$6.5K
PCH
87
DELISTED
PotlatchDeltic
PCH
$234K 0.19%
5,714
-153
-3% -$7.23K
APOG icon
88
Apogee Enterprises
APOG
$833M
– –
-5,693
Closed -$275K
BLUE
89
DELISTED
bluebird bio
BLUE
– –
-362
Closed -$737K
CRM icon
90
Salesforce
CRM
$154B
– –
-1,539
Closed -$209K
EHC icon
91
Encompass Health
EHC
$11.3B
– –
-9,534
Closed -$513K
FIX icon
92
Comfort Systems
FIX
$53.5B
– –
-7,513
Closed -$344K
GDXJ icon
93
VanEck Junior Gold Miners ETF
GDXJ
$6.86B
– –
-56,300
Closed -$1.84M
NTLA icon
94
Intellia Therapeutics
NTLA
$1.51B
– –
-18,735
Closed -$513K
SIL icon
95
Global X Silver Miners ETF NEW
SIL
$3.93B
– –
-32,500
Closed -$939K
JBTM
96
JBT Marel
JBTM
$7.35B
– –
-6,150
Closed -$547K
NUVA
97
DELISTED
NuVasive, Inc.
NUVA
– –
-6,878
Closed -$358K
LHCG
98
DELISTED
LHC Group LLC
LHCG
– –
-6,409
Closed -$549K
IOTS
99
DELISTED
Adesto Technologies Corp
IOTS
– –
-72,040
Closed -$605K
MXWL
100
DELISTED
Maxwell Technologies Inc
MXWL
– –
-26,932
Closed -$140K
1 2 3
4

Similar funds

CIM
Consilium Investment Management Ft. Lauderdale, Florida $21M AUM 29.5% 1-Year Est. Return
ICP
IBIS Capital Partners London, United Kingdom $19.4M AUM 0.49% 1-Year Est. Return
QI
Quilter Investors London, United Kingdom $22.3M AUM 6.63% 1-Year Est. Return
HWM
Highwater Wealth Management Glendale, Colorado $22.6M AUM 3.46% 1-Year Est. Return
AGU
Alpine Group USVI St. Thomas, U.S. Virgin Islands $23.4M AUM
PCP
Prisma Capital Partners New York $17.5M AUM 42.28% 1-Year Est. Return
MAU
MRA Associates USA Phoenix, Arizona $25.4M AUM 0.38% 1-Year Est. Return
FCG
FrontFour Capital Group Greenwich, Connecticut $26.5M AUM 17.69% 1-Year Est. Return

Pacific View Asset Management's Q3 2018 Portfolio in Review

As of Q3 2018, Pacific View Asset Management held 100 positions worth $126M, down 0.54% from $126M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Pacific View Asset Management's Q3 2018 filing shows 5 new, 28 increased, 51 reduced and 13 closed positions. Its largest new stake was Spectrum Pharmaceuticals Inc: 57,885 shares worth $972K. The largest sale was Sage Therapeutics, an estimated $4.13M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Pacific View Asset Management's largest Q3 2018 buy was Spectrum Pharmaceuticals Inc: 57,885 shares worth $972K.
  • Pacific View Asset Management added most to Limbach Holdings in Q3 2018, an estimated $2.96M increase.
  • Pacific View Asset Management's biggest Q3 2018 reduction was Sage Therapeutics, cutting an estimated $4.13M.
  • Pacific View Asset Management fully exited VanEck Junior Gold Miners ETF in Q3 2018, selling an estimated $1.84M.
  • Pacific View Asset Management's ten largest holdings make up 44% of its $126M portfolio in Q3 2018.
  • Pacific View Asset Management opened 5 new positions and closed 13 in Q3 2018.
  • Pacific View Asset Management's portfolio value fell 0.54% quarter-over-quarter to $126M.

Based on Pacific View Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.